You are here



It is a company dedicated to nutraceutics development, pharmacogenetics solutions and research in innovative treatments for lung cancer. The company generates an income of 2,1 million euros.


The financing of the projects is provided by the Ministry of Science and Innovation through the programme Knowledge Transmission to Enterprise.


This company, founded by Dr. Ignasi Belda, sets up its first subsidiary in one of the pioneers in the entire world in life sciences.


BioEmprenedorXXI is a joint public-private initiative from “la Caixa”, the Barcelona City Council, Biocat, Genoma España and the Barcelona Chamber of Commerce.


Last year Sepmag participated in the biotec world trade show in Atlanta, as part of the delegation of companies coordinated by Biocat.


VCN Biosciencies is a spin-off that is devoted to the innovative field of virotherapy, specifically in administering genetically modified viruses to destroy tumor cells.


Ignasi Faus, CEO of Palau Pharma, reveals the keys of their success and gives us his point of view in relation to the BioRegion of Catalonia challenges and potentiality.



Parente is co-founder and general director of Lipotec, one of the most emblematic company groups of the BioRegion of Catalonia.